[Disclosure] Celltrion (068270) – CHMP Recommendation for Marketing Authorization for CT-P42 (Eylea Biosimilar) / 2024-12-16
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received a recommendation for marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) for CT-P42, a biosimilar referencing Eylea, across 30 European countries for four indications including neovascular (wet) age-related macular degeneration. 📊 Key Disclosure Content…